← back to search

Sonja W. Scholz

Johns Hopkins University · US
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological diseases and metabolism, Amyotrophic Lateral Sclerosis Research, and Genetic Neurodegenerative Diseases.
h-index
59
citations
26,823
works
266
NIH funding
primary concept
email

Recent publications

Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease
Annals of Neurology 2025cited by 0position: middledoi
Detection of mosaic and population-level structural variants with Sniffles2
Nature Biotechnology 2024cited by 422position: middledoi
<scp>NeuroBooster</scp> Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations
Movement Disorders 2024cited by 38position: middledoi
Mechanism-Free Repurposing of Drugs For&amp;nbsp;C9orf72-related ALS/FTD Using Large-Scale Genomic Data
SSRN Electronic Journal 2024cited by 0position: middledoi
Mechanism-Free Repurposing of Drugs For&amp;nbsp;C9orf72-Related ALS/FTD Using Large-Scale Genomic Data
SSRN Electronic Journal 2024cited by 0position: middledoi
Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation
Nature Methods 2023cited by 139position: middledoi
Large-scale rare variant burden testing in Parkinson's disease
Brain 2023cited by 50position: middledoi
Genome‐Wide Analysis of Structural Variants in Parkinson Disease
Annals of Neurology 2023cited by 37position: middledoi
Unexpected frequency of the pathogenic <i>AR</i> CAG repeat expansion in the general population
Brain 2023cited by 28position: middledoi
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Cell stem cell 2022cited by 293position: middledoi
Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
npj Parkinson s Disease 2022cited by 108position: middledoi
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design
Alzheimer s & Dementia 2022cited by 93position: middledoi
Personality traits are consistently associated with blood mitochondrial DNA copy number estimated from genome sequences in two genetic cohort studies
medRxiv 2022cited by 2position: middledoi
Challenges in the diagnosis of Parkinson's disease
The Lancet Neurology 2021cited by 1,708position: middledoi
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications 2021cited by 213position: middledoi
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
Movement Disorders 2021cited by 128position: middledoi
A reference induced pluripotent stem cell line for large-scale collaborative studies
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 13position: middledoi
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
The Lancet Neurology 2020cited by 119position: middledoi
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
Acta Neuropathologica 2020cited by 117position: middledoi
Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts
Neuron 2020cited by 116position: middledoi
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications 2020cited by 37position: middledoi
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet Neurology 2019cited by 2,513position: middledoi
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
Movement Disorders 2019cited by 373position: middledoi
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
Brain 2019cited by 245position: middledoi
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson s Disease 2019cited by 161position: middledoi
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica 2019cited by 130position: middledoi
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson s Disease 2019cited by 111position: middledoi
A critique of the second consensus criteria for multiple system atrophy
Movement Disorders 2019cited by 92position: middledoi
Heritability and genetic variance of dementia with Lewy bodies
Neurobiology of Disease 2019cited by 44position: middledoi
Parkinson disease age of onset GWAS: defining heritability, genetic loci and a-synuclein mechanisms
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew Singleton · University of Birmingham3 papers (2014–2022)Cornelis Blauwendraat · National Institute for Public Health and the Environment2 papers (2021–2022)Hirotaka Iwaki · National Institute of Neurological Disorders and Stroke2 papers (2021–2022)Mike A. Nalls · Alzheimer's Association2 papers (2021–2022)Susan M. Resnick · New York University2 papers (2020–2022)Hampton L. Leonard · Alzheimer's Association2 papers (2021–2022)Bryan J. Traynor · National Institutes of Health2 papers (2012–2022)Mahdiar Sadeghi · Northeastern University1 papers (2021–2021)Luigi Ferrucci · Banyan Biomarkers (United States)1 papers (2022–2022)Juan C. Troncoso · Johns Hopkins Hospital1 papers (2020–2020)Philip L. De Jager · Mayo Clinic in Florida1 papers (2020–2020)Andrea Calvo · Amyotrophic Lateral Sclerosis Association1 papers (2012–2012)Steven Jacobson · National Institute of Allergy and Infectious Diseases1 papers (2020–2020) · 1 papers (2024–2024)Dag Aarsland · Transnational Press London1 papers (2022–2022)Alastair J. Noyce · Queen Mary University of London1 papers (2022–2022)James B. Leverenz · Cleveland Clinic1 papers (2022–2022)Xianjun Dong · Yale Cancer Center1 papers (2021–2021) · 1 papers (2012–2012)Martin Picard · McGill University Health Centre1 papers (2022–2022)